Video index

1. Call to order

2. Consideration of January 31, 2025, draft meeting minutes (Part 1 of 2)

3. DURB chair and vice-chair elections

4. Public comment and discussion on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL):

5. Public comment and discussion on single new drugs to be reviewed for the Medicaid PDL:

6. Therapeutic and clinical drug reviews and updates, discussion, andrecommendations: Gainwell Technologies and DURB members

7. Executive work session Pursuant to Texas Government Code, Section 531.071, and in accordance with TexasAdministrative Code, Title 1, Part 15, Subchapter F, Section 354.1941(c)(2), theDURB may meet in executive session on one or more items listed under publiccomment on the drug classes to be reviewed for the Medicaid PDL, and as permittedby the Texas Open Meetings Act.

2. Consideration of January 31, 2025, draft meeting minutes (Part 2 of 2)

8. Announcements of drugs recommended for the Medicaid PDL: OptumRx

9. Retrospective drug utilization review (DUR): Acentra Health

10. Prospective prior authorization proposals: Acentra Health

11. Retrospective drug use criteria for outpatient use in the Vendor Drug Program: The University of Texas at Austin College of Pharmacy

12. Review of action items for next meeting

Apr 25, 2025 Drug Utilization Review Board

Full agenda
Share this video

1. Call to order

2. Consideration of January 31, 2025, draft meeting minutes (Part 1 of 2)

3. DURB chair and vice-chair elections

4. Public comment and discussion on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL):

5. Public comment and discussion on single new drugs to be reviewed for the Medicaid PDL:

6. Therapeutic and clinical drug reviews and updates, discussion, andrecommendations: Gainwell Technologies and DURB members

7. Executive work session Pursuant to Texas Government Code, Section 531.071, and in accordance with TexasAdministrative Code, Title 1, Part 15, Subchapter F, Section 354.1941(c)(2), theDURB may meet in executive session on one or more items listed under publiccomment on the drug classes to be reviewed for the Medicaid PDL, and as permittedby the Texas Open Meetings Act.

2. Consideration of January 31, 2025, draft meeting minutes (Part 2 of 2)

8. Announcements of drugs recommended for the Medicaid PDL: OptumRx

9. Retrospective drug utilization review (DUR): Acentra Health

10. Prospective prior authorization proposals: Acentra Health

11. Retrospective drug use criteria for outpatient use in the Vendor Drug Program: The University of Texas at Austin College of Pharmacy

12. Review of action items for next meeting

© 2003-2025 Swagit Productions, LLC